Mittie Doyle

Mittie Doyle

Chief Tech/Sci/R&D Officer at AVALO THERAPEUTICS, INC.

Net worth: 956 820 $ as of 30/06/2026

61 year
Health Technology
Consumer Services

Profile

Dr. Mittie Doyle, MD, is a Chief Medical Officer at Avalo Therapeutics, Inc. She is on the Board of Directors at Cullinan Therapeutics, Inc. and Santa Ana Bio, Inc. Dr. Doyle was previously employed as an Independent Director by DICE Therapeutics, Inc., a Chief Medical Officer by Aro Biotherapeutics Co., a VP-Global Therapeutic, Head-Research & Development by CSL Behring LLC, a Vice President-Global Development Lead by Shire Pharmaceuticals, Inc., a Vice President-Clinical Research by Flexion Therapeutics, Inc., and a Senior Medical Director by Alexion Pharmaceuticals, Inc. She received her undergraduate degree from Princeton University and a doctorate degree from Yale School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/07/2026 51,776 ( 0.1% ) 956 820 $ 30/06/2026

Mittie Doyle active positions

CompaniesPositionStart
AVALO THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 15/07/2024
CULLINAN THERAPEUTICS, INC. Director/Board Member 07/08/2025
Director/Board Member -

Former positions of Mittie Doyle

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/07/2024
DICE THER Director/Board Member 09/08/2023
Chief Tech/Sci/R&D Officer 01/10/2021
Corporate Officer/Principal 01/10/2017
FLEXION THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/08/2016
See the detail of Mittie Doyle's experience

Training of Mittie Doyle

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology